ストックスクリーナーアプリを入手
2.435
1.45%
0.025
Organogenesis Holdings Inc (ORGO) 最新ニュース
Income Plays: Is Organogenesis Holdings Inc benefiting from innovation trendsDividend Hike & Target Return Focused Picks - baoquankhu1.vn
Aug Summary: Is Organogenesis Holdings Inc impacted by rising ratesWatch List & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Trading Recap: How does Organogenesis Holdings Inc correlate with Nasdaq2026 Analyst Calls & Growth Focused Stock Pick Reports - baoquankhu1.vn
Amniotic Membrane Market Is Booming Rapidly and Thriving by 2033 - openPR.com
Organogenesis $ORGO Shares Acquired by First Light Asset Management LLC - MarketBeat
Insider Buying: Organogenesis (NASDAQ:ORGO) Director Buys $13,400.00 in Stock - MarketBeat
Organogenesis director Leibowitz buys $13k in ORGO stock By Investing.com - Investing.com Canada
Insider Buying: Michael Driscoll Acquires Shares of Organogenesis Holdings Inc (ORGO) - GuruFocus
Organogenesis director Leibowitz buys $13k in ORGO stock - Investing.com
Director at Organogenesis (NASDAQ: ORGO) purchases 5,000 shares - Stock Titan
Organogenesis (NASDAQ:ORGO) Director Michael Joseph Driscoll Purchases 10,000 Shares of Stock - MarketBeat
Organogenesis (ORGO) director adds 10,000 shares in open-market purchase - Stock Titan
Organogenesis (NASDAQ:ORGO) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Organogenesis (NASDAQ:ORGO) Upgraded by Wall Street Zen to “Buy” Rating - Defense World
Earnings Beat: Will Organogenesis Holdings Inc. stock gain from lower inflationWeekly Trade Report & Verified Technical Signals - Naître et grandir
Organogenesis (ORGO) VP uses 700 shares to cover tax withholding - Stock Titan
Organogenesis (ORGO) VP amends Form 4 for equity grant and tax withholding - Stock Titan
ORGO (Organogenesis) CEO amends Form 4 for stock grant and tax share disposal - Stock Titan
[Form 4/A] Organogenesis Holdings Inc. Amended Insider Trading Activity - Stock Titan
Organogenesis (ORGO) VP updates Form 4 for award vesting and tax shares - Stock Titan
Organogenesis (NASDAQ: ORGO) officer amends Form 4 for award and tax-withheld shares - Stock Titan
BTIG Research Cuts Organogenesis (NASDAQ:ORGO) Price Target to $8.00 - Defense World
Organogenesis Earnings Call: Record Highs Meet Policy Shock - TipRanks
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2025 Earnings Call Transcript - Insider Monkey
ORGO PE Ratio & Valuation, Is ORGO Overvalued - Intellectia AI
Wall Street Zen Downgrades Organogenesis (NASDAQ:ORGO) to Hold - MarketBeat
Organogenesis Holdings Inc. (ORGO) Stock Analysis: Unveiling a Potential 116% Upside in Healthcare Innovation - DirectorsTalk Interviews
Organogenesis Holdings (ORGO) Margin-Driven Profitability Shift Tests Revenue Concern Narratives - simplywall.st
Organogenesis (ORGO) CAO files Form 3 detailing stock and RSUs - Stock Titan
Organogenesis Holdings Reports Q4 2025 Results: Full Earnings Call Transcript - Benzinga
Organogenesis (NASDAQ:ORGO) Price Target Cut to $8.00 by Analysts at BTIG Research - MarketBeat
Organogenesis Q4 Earnings Call Highlights - Yahoo Finance
Organogenesis Holdings Inc (ORGO) Q4 2025 Earnings Call Highlights: Record Revenue Growth Amid ... - Investing.com Canada
Organogenesis (ORGO) Q4 2025 Earnings Transcript - AOL.com
Earnings call transcript: Organogenesis Q4 2025 beats expectations but faces market challenges - Investing.com Canada
ORGO: Record Q4 revenue, but 2026 guidance signals a sharp decline before expected recovery - TradingView
Organogenesis: Q4 Earnings Snapshot - Barchart.com
Organogenesis Holdings Inc. (ORGO) Stock Rises on Q4 2025 Earnings - Quiver Quantitative
ORGO: Record 2025 results, but 2026 revenue expected to decline due to CMS changes before recovery - TradingView
Wound-care firm Organogenesis hits record sales, warns 2026 drop up to 38% - Stock Titan
Organogenesis (NASDAQ:ORGO) Issues Quarterly Earnings Results, Beats Expectations By $0.10 EPS - MarketBeat
A Preview Of Organogenesis Hldgs's Earnings - Benzinga
Published on: 2026-02-25 08:32:12 - baoquankhu1.vn
Organogenesis Holdings Inc expected to post earnings of 21 cents a shareEarnings Preview - TradingView
Organogenesis Names Patrick McGuire Chief Accounting Officer - The Globe and Mail
Organogenesis (Nasdaq: ORGO) appoints Patrick McGuire as CAO - Stock Titan
Organogenesis Holdings Inc. Announces Executive Changes, Effective February 18, 2026 - marketscreener.com
Organogenesis (NASDAQ: ORGO) legal chief granted options, RSUs and settles taxes - Stock Titan
Executive equity awards at Organogenesis (ORGO) include RSUs, options and tax withholding - Stock Titan
Organogenesis Holdings (NASDAQ: ORGO) COO gets new stock and option awards - Stock Titan
Equity grant gives Organogenesis (ORGO) director 48,828 RSUs vesting 2027 - Stock Titan
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
48,828 RSUs granted to Organogenesis (ORGO) director Arthur Leibowitz - Stock Titan
What’s the fair value of Organogenesis Holdings Inc. stockJuly 2025 Price Swings & Verified Momentum Stock Ideas - mfd.ru
Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring a 113% Potential Upside in Healthcare Innovation - DirectorsTalk Interviews
Stem Cell and Regenerative Therapy Markets, 2022-2025 & Forecast to 2030 Featuring Profiles of Leading CompaniesGilead Sciences, Novartis, Bristol-Myers Squibb, Organogenesis, MiMedx Group and More - Yahoo Finance
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026 - The Manila Times
Regenerative medicine firm Organogenesis sets Feb. 26 call on 2025 results - Stock Titan
Organogenesis (NASDAQ: ORGO) VP uses 18,619 shares to cover tax liability - Stock Titan
Published on: 2026-02-18 01:47:23 - mfd.ru
3.09%
大文字化:
|
ボリューム (24 時間):